Evidence‑Based Management of Belching

Differentiation of Belching Types

Supragastric belching is a voluntary, behavioral phenomenon in which air enters the esophagus and is expelled without reaching the stomach; it ceases during sleep, distraction, or speaking, indicating a psychogenic component【2】【3】.
Gastric belching is an involuntary, forceful expulsion of air originating from the stomach and is frequently linked to gastro‑esophageal reflux disease (GERD)【4】.
High‑resolution manometry with impedance monitoring for at least 90 minutes (preferably 24 hours) provides definitive discrimination between supragastric and gastric belching when clinical assessment is uncertain【1】【4】.

Brain‑gut behavioral therapies—including diaphragmatic breathing, speech therapy, and cognitive‑behavioral therapy (CBT)—are the cornerstone of treatment for supragastric belching【1】.
Psychoeducation that presents impedance tracings to the patient functions as biofeedback, helping individuals recognize and modify their belching pattern【3】.
Supragastric belching shows a strong association with anxiety and obsessive‑compulsive disorder, underscoring the need to address psychosocial triggers in therapy【2】【3】.

Antidepressants may be added to behavioral programs to diminish visceral hypersensitivity, raise sensory thresholds, and treat co‑existing psychological conditions【1】.

Initial management consists of proton‑pump inhibitor (PPI) therapy combined with lifestyle modifications (e.g., diet, head‑of‑bed elevation) to control reflux‑related belching【4】.
Adding diaphragmatic breathing to PPI therapy yields superior reduction of both belching frequency and PPI‑refractory GERD symptoms compared with PPI alone【3】.
In patients with severe, pathologic GERD, anti‑reflux surgery (fundoplication) should be considered【4】.
Baclofen can be employed when excessive transient lower‑esophageal sphincter relaxations are identified as a contributing mechanism【4】.

Begin with a two‑week dietary elimination trial to identify intolerances (e.g., lactose, fructose, artificial sweeteners) before pursuing advanced testing【5】.
If symptoms persist, perform hydrogen breath testing to detect small‑intestinal bacterial overgrowth (SIBO) or carbohydrate malabsorption【5】.
Confirmed SIBO should be treated with an appropriate antimicrobial regimen【5】.
Patients should avoid artificial sweeteners such as sorbitol and other sugar alcohols that promote malabsorption and bacterial fermentation【5】.

Rumination disorder should be excluded using high‑resolution manometry with impedance monitoring【4】.
Aerophagia may be considered when manometry demonstrates air influx during swallowing that leads to intestinal gas accumulation【4】.
Constipation, which prolongs intestinal transit and enhances bacterial fermentation, ought to be assessed and managed as a contributory factor【5】.
Probiotics are not recommended for the treatment of belching or bloating【1】.
PPI monotherapy is ineffective for supragastric belching that occurs independent of acid reflux, as these episodes are typically non‑acidic【3】.
Routine gastric emptying studies are discouraged unless the patient presents with prominent nausea or vomiting, which may indicate gastroparesis【1】.

Clinical differentiation: Identify supragastric belching by its cessation with distraction and gastric belching by accompanying GERD symptoms【2】【4】.
Supragastric pathway: Psychoeducation → diaphragmatic breathing or speech therapy → add CBT or central neuromodulators as needed【1】【3】.
Gastric pathway: PPI + lifestyle changes → add diaphragmatic breathing → consider baclofen or fundoplication for refractory cases【4】【3】.
Sulfur‑odor pathway: Dietary elimination → breath testing if persistent → treat SIBO or malabsorption accordingly【5】.